Revvityブログ
発見から治療までのイノベーションを促進
Latest
From policy to practice: what FDA's 2025 direction means for your precision medicine pipeline.
Cell and Gene Therapy
December 8, 2025 - 5 min read
Clinical Genomics
Genetic testing: a critical tool for diagnosing rare disorders and enhancing patient care.
February 26, 2025 -
4 min read
Neuroscience Research
Detecting total and phospho-ser129 α-synuclein in preclinical models.
February 24, 2025 -
7 min read
Disease Research
What to consider when choosing sonicators for tissue and cell lysis.
February 21, 2025 -
5 min read
Functional Genomic Screening
Mastering screening: Validating and following up on hits from loss-of-function screens.
February 20, 2025 -
2 min read
Small Molecule Drug Discovery
Enhancing drug development with advanced immune profiling.
February 19, 2025 -
2 min read
Cell and Gene Therapy
Cell and gene therapy gets on point with base editors.
February 19, 2025 -
6 min read
Cancer
Lentiviral sgRNA CRISPR screening in primary human immune cells.
February 19, 2025 -
2 min read
Reproductive Health
Empowering lives: Revvity's commitment to rare disease awareness.
February 19, 2025 -
3 min read
Cell and Gene Therapy
Base editing goes big: A role in functional pooled screening.
February 14, 2025 -
4 min read
